arrow
M

Mohammad Mahdavi

Tehran University of Medical Sciences
H指数:47
被引数:9,830

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Diphenylpiperazine attached to different triazole acetamide derivatives as a potent α-glucosidase inhibitor, new insight into the in silico study of an uncompetitive inhibitor

校正:连接到不同三唑乙酰胺衍生物的双苯基哌嗪作为强效α-葡萄糖苷酶抑制剂,对非竞争性抑制剂的计算机模拟研究提供了新的见解

2026-11-060
PRE
Synthesis, α-glucosidase inhibition, and antidiabetic evaluation of 2-phenylquinoline-indole hydrazine hybrids: In vitro, in vivo, and computational studies

2-苯基喹啉-吲哚酰肼类化合物的合成、α-葡糖苷酶抑制活性及抗糖尿病评价:<em>体外</em>、<em>体内</em>及计算研究

2026-10-160
OAAI
Synthesis, in vitro evaluation and molecular docking of amino-kojic acid derivatives as potent tyrosinase and urease inhibitors

氨基曲酸衍生物的合成、体外评价及其作为酪氨酸酶和脲酶强效抑制剂的分子对接研究

2026-09-300
PRE
Design, synthesis, and in vitro/in vivo evaluation of novel diphenyl-1,2,4-triazine-3-yl-thioacetamide-chalcone hybrids as potent α-glucosidase inhibitors targeting type 2 diabetes

新型二苯基-1,2,4-三嗪-3-基-硫代乙酰胺-查尔酮杂合物的设计、合成及体内外评价:作为靶向2型糖尿病的强效α-葡萄糖苷酶抑制剂

2026-08-280
PRE
Design, synthesis, and evaluation of the rhodanine-3-propanoic acid-phenoxy-1,2,3-triazole-acetamide derivatives as active agents against α-glucosidase, α-amylase, and protein tyrosine phosphatase 1B

设计、合成及评价罗丹宁-3-丙酸-苯氧基-1,2,3-三唑基-乙酰胺衍生物作为α-葡萄糖苷酶、α-淀粉酶和蛋白酪氨酸磷酸酶1B的活性抑制剂

2025-10-300
PRE
Chroman, pyridine, and coumarin in a new fused scaffold as α-glucosidase inhibitor: synthesis of new derivatives, in vitro, and in silico evaluations

Chroman、pyridine及coumarin作为α-葡糖苷酶抑制剂的新型稠合骨架:新衍生物的合成、体外及计算机模拟评估

2025-10-220
PRE
Correction: Magnetized chitosan hydrogel and silk fibroin; reinforced with PVA: a novel nanobiocomposite for biomedical and hyperthermia applications

更正:磁化壳聚糖水凝胶和丝素;用PVA增强:一种用于生物医学和热疗应用的新型纳米生物复合材料

2025-10-080
OAAI
New 1E; 1′E-hydrazine-bis(phenoxy-1; 2; 3-triazol-acetamide) derivatives as potent inhibitors against acetylcholinesterase; butyrylcholinesterase; and α-glucosidase

新1E;1′E-肼基-双(苯氧基-1;2;3-三唑-乙酰胺)衍生物作为乙酰胆碱酯酶、丁酰胆碱酯酶和α-葡萄糖苷酶的强效抑制剂

2025-08-220
OA